US Congress Reviews Medicaid Fraud and Opioid Crisis
美國國會審查醫療補助詐欺與鴉片類藥物危機
更新於: 2026年6月25日 上午02:15
Congress has intensified its focus on the integrity of the Medicaid program.
醫療補助計畫為近7500萬名美國人提供服務，預算超過6000億美元，已成為調查詐欺、浪費和濫用行為的主要目標。
Serving nearly 75 million Americans with a budget exceeding $600 billion, Medicaid has become a primary target for investigations into fraud, waste, and abuse.
議員們目前正在審查各州是否具備必要的監督工具，以保護這個關鍵的安全網免受複雜騙局的侵害，這些騙局包括空殼醫療提供者，以及安寧療護和居家照護計畫中的不當帳單。
A major area of concern is the intersection of these financial crimes with the national opioid epidemic.
當局正致力於瓦解透過醫療補助計畫取得處方藥並非法販售的陰謀。
Authorities are working to dismantle schemes where prescription drugs obtained through Medicaid are sold illicitly.
為了解決這些問題，美國衛生與公共服務部(Department of Health and Human Services)正採取激進措施，例如扣留不合規州的聯邦資金。
To combat these issues, the Department of Health and Human Services is taking aggressive steps, such as withholding federal funds from non-compliant states.
同時，國會正在考慮通過新法案，如《阻止尼他嗪法案》(STOP Nitazenes Act)，以應對合成鴉片類藥物的興起。
Simultaneously, Congress is considering new legislation, like the STOP Nitazenes Act, to address the rise of synthetic opioids.
這種情況造成了一個困難的平衡行為：聯邦政府必須使監督現代化以確保財政永續性，但在打擊非法行為者所利用的漏洞的同時，也必須小心不要限制弱勢群體獲得基本醫療保健的管道。
This situation creates a difficult balancing act: the federal government must modernize oversight to ensure fiscal sustainability, yet it must also be careful not to limit access to vital healthcare for vulnerable populations, including seniors and children, as it fights to close loopholes exploited by illicit actors.
